Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Showing 12 of 0 results

Large-scale testing (Phase 3)Study completedNCT02573324
What this trial is testing

ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification

Who this might be right for
GlioblastomaGliosarcoma
AbbVie 691
Very early researchLooking for participantsNCT06072586
What this trial is testing

BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

Who this might be right for
High Grade GliomaGlioblastoma
St. Joseph's Hospital and Medical Center, Phoenix 82
Testing effectiveness (Phase 2)Study completedNCT00128700
What this trial is testing

Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 20
Large-scale testing (Phase 3)Ended earlyNCT03393000
What this trial is testing

Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects

Who this might be right for
Glioblastoma
Diffusion Pharmaceuticals Inc 19
Post-approval studies (Phase 4)UnknownNCT05235737
What this trial is testing

The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab

Who this might be right for
Newly Diagnosed Glioblastoma
Medical University of Silesia 36
Testing effectiveness (Phase 2)UnknownNCT05447195
What this trial is testing

Phase 2 Study of CAN008 in Subjects With GBM

Who this might be right for
Newly-diagnosed Glioblastoma
CANbridge Life Sciences Ltd. 117
Not applicableLooking for participantsNCT07375992
What this trial is testing

Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)

Who this might be right for
Glioblastoma (GBM)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Not applicableEnded earlyNCT00471653
What this trial is testing

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

Who this might be right for
Brain and Central Nervous System TumorsThrombocytopenia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Early research (Phase 1)Study completedNCT00004212
What this trial is testing

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Daiichi Sankyo
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195139
What this trial is testing

Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM

Who this might be right for
Glioblastoma Multiforme
University of Sydney 103
Testing effectiveness (Phase 2)Study completedNCT02206230
What this trial is testing

Trial of Hypofractionated Radiation Therapy for Glioblastoma

Who this might be right for
Glioblastoma
AHS Cancer Control Alberta 133
Early research (Phase 1)Active Not RecruitingNCT03011671
What this trial is testing

Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma

Who this might be right for
Malignant Glioma of Brain
University of Chicago 10

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation